Influence of the Sinus Floor-to-lower Window Margin Distance on Outcomes of Bone Window Repositioning in Lateral Sinus Floor Elevation With Simultaneous Implant Placement
NCT ID: NCT07045389
Last Updated: 2025-07-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
47 participants
OBSERVATIONAL
2019-03-01
2024-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Does a sinus floor-to-window margin distance ≥3 mm lead to better bone augmentation and implant stability compared to a distance \<3 mm?
This is a retrospective, single-center cohort study. Participants included patients who had previously undergone lateral sinus floor elevation with implant placement and had at least 6 months of postoperative follow-up. Cone-beam CT images were used to measure radiographic outcomes such as alveolar bone height and augmented volume.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Different Window-preparation Approaches on the Clinical Outcomes of Lateral Sinus Floor Elevation
NCT06323993
The Systematic Evaluation of the Surgery, Using the Ratio of the Window Area to the Volume of Bone Graft Material
NCT06654492
Effectiveness in Limiting the Need to Elevate the Maxillary Sinus
NCT03357705
Concentrated Growth Factors Applied in Maxillary Sinus Floor Elevation Via a Lateral Window Approach
NCT03046173
Influence of Anatomy of Maxillary Sinus on New Bone Formation After Transcrestal Augmentation Procedures
NCT03209284
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DSLW ≥ 3 mm
Patients undergoing lateral sinus floor elevation with simultaneous implant placement, in whom the distance from the sinus floor to the lower edge of the lateral window is greater than or equal to 3 mm.
No interventions assigned to this group
DSLW < 3 mm
Patients undergoing lateral sinus floor elevation with simultaneous implant placement, in whom the distance from the sinus floor to the lower edge of the lateral window is less than 3 mm.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Received lateral sinus floor elevation with bone window repositioning and simultaneous implant placement (LSFE with BWR and SIP) between 2019 and 2024
* No contraindications to implantation
* Complete medical and radiographic records available
Exclusion Criteria
* Incomplete medical or surgical records
* Missing preoperative or postoperative imaging data
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Natural Science Foundation of China
OTHER_GOV
The Dental Hospital of Zhejiang University School of Medicine
OTHER
Guoli Yang
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Guoli Yang
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Affiliated Hospital, School of Stomatology, Zhejiang University.
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
82271001; 82370991; 2022KY872
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2024-204R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.